Citadel Advisors’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-204
| Closed | -$15.7K | – | 6767 |
|
|
2023
Q4 | $15.7K | Buy |
+204
| New | +$15.7K | ﹤0.01% | 5438 |
|
|
2022
Q3 | – | Sell |
-55
| Closed | -$35K | – | 6638 |
|
|
2022
Q2 | $35K | Buy |
+55
| New | +$35K | ﹤0.01% | 5600 |
|
|
2021
Q3 | – | Sell |
-28
| Closed | -$91K | – | 7020 |
|
|
2021
Q2 | $91K | Buy |
28
+23
| +460% | +$74.8K | ﹤0.01% | 6004 |
|
|
2021
Q1 | $21K | Buy |
+5
| New | +$21K | ﹤0.01% | 6186 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$20K | – | 4989 |
|
|
2018
Q4 | $20K | Buy |
+1
| New | +$20K | ﹤0.01% | 4279 |
|
|
2016
Q3 | – | Hold |
0
| – | -$104K | – | 4016 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 2952 |
|
|
2016
Q1 | – | Hold |
0
| – | -$59K | – | 3885 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3401 |
|